ATRIAL FIBRILLATION COMBINED WITH ARTERIAL HYPERTENSION AND OBESITY PARADOX

Purpose. To study the peculiarities of the clinical course of atrial fibrillation in patients with arterial hypertension and obesity.Materials and methods. 127 patients were observed within the observational cohort studies. Of these, 64 patients with atrial fibrillation, arterial hypertension and ob...

Full description

Saved in:
Bibliographic Details
Main Authors: L. D. Khidirova, D. A. Yakhontov, T. S. Kuropiy, S. A. Zenin
Format: Article
Language:Russian
Published: InterMedservice 2019-03-01
Series:Евразийский Кардиологический Журнал
Subjects:
Online Access:https://www.heartj.asia/jour/article/view/317
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849244990373363712
author L. D. Khidirova
D. A. Yakhontov
T. S. Kuropiy
S. A. Zenin
author_facet L. D. Khidirova
D. A. Yakhontov
T. S. Kuropiy
S. A. Zenin
author_sort L. D. Khidirova
collection DOAJ
description Purpose. To study the peculiarities of the clinical course of atrial fibrillation in patients with arterial hypertension and obesity.Materials and methods. 127 patients were observed within the observational cohort studies. Of these, 64 patients with atrial fibrillation, arterial hypertension and obesity in the control group, while the experimental group consisted of 63 patients with atrial fibrillation, arterial hypertension and normal BMI (24.1±2.2) kg/m2. During our work we assessed clinical, anthropometric and laboratory indicators, as well as the results of instrumental examination: ElectroCG; Daily monitoring of ECG, EchoCG. Comparison of binary and categorical indicators was carried out upon an accurate bilateral F test. Statistical hypothesis testing was carried out at critical significance value p=0.05, i.e. the difference was considered statistically significant if p<0.05.Results. Body mass index (BMI) in patients with atrial fibrillation, hypertension and obesity amounted to 35.2±4.6 kg/m2. The average age in all clinical groups was 60.5±9.2 years old, and patients with obesity were significantly younger (p<0.05) - 53.3±6.1 years old than patients with normal BMI - who were 59.8±7.4 years old. Patients with hypertension, atrial fibrillation and obesity often had a persistent form of AF 71%. General assessment of the lipid profile indicated that only patients with obesity and hypothyroidism showed a significantly high level of triglycerides. (p<0.001). There was an increase in NT-proBNP (p=0.001) and galectin-3 (p=0.005). There was a consistent increase of the end-diastolic dimension of the left ventricle in the left atrium; thickening of the left ventricular posterior and the interventricular septum in compared groups proved equivocal, while the LVMMI (p<0.05) was significantly lower in patients with obesity than in the experimental group.Conclusion. The presence of obesity in patients with atrial fibrillation and arterial hypertension adversely affects certain biochemical and ultrasound parameters, however, many of the criteria characterizing cardiovascular risk and prognosis did not reveal significant differences, which requires further in-depth study of this problem and identification of a possible “obesity paradox” in the group of patients with atrial fibrillation, arterial hypertension and obesity.
format Article
id doaj-art-4be663e5bccc4ff6b4bbd350822e39f5
institution Kabale University
issn 2225-1685
2305-0748
language Russian
publishDate 2019-03-01
publisher InterMedservice
record_format Article
series Евразийский Кардиологический Журнал
spelling doaj-art-4be663e5bccc4ff6b4bbd350822e39f52025-08-20T03:58:59ZrusInterMedserviceЕвразийский Кардиологический Журнал2225-16852305-07482019-03-010141310.38109/2225-1685-2019-1-4-13316ATRIAL FIBRILLATION COMBINED WITH ARTERIAL HYPERTENSION AND OBESITY PARADOXL. D. Khidirova0D. A. Yakhontov1T. S. Kuropiy2S. A. Zenin3Novosibirsk State Medical UniversityNovosibirsk State Medical UniversityNovosibirsk State Medical UniversityNovosibirsk Regional Clinical Cardiology DispensaryPurpose. To study the peculiarities of the clinical course of atrial fibrillation in patients with arterial hypertension and obesity.Materials and methods. 127 patients were observed within the observational cohort studies. Of these, 64 patients with atrial fibrillation, arterial hypertension and obesity in the control group, while the experimental group consisted of 63 patients with atrial fibrillation, arterial hypertension and normal BMI (24.1±2.2) kg/m2. During our work we assessed clinical, anthropometric and laboratory indicators, as well as the results of instrumental examination: ElectroCG; Daily monitoring of ECG, EchoCG. Comparison of binary and categorical indicators was carried out upon an accurate bilateral F test. Statistical hypothesis testing was carried out at critical significance value p=0.05, i.e. the difference was considered statistically significant if p<0.05.Results. Body mass index (BMI) in patients with atrial fibrillation, hypertension and obesity amounted to 35.2±4.6 kg/m2. The average age in all clinical groups was 60.5±9.2 years old, and patients with obesity were significantly younger (p<0.05) - 53.3±6.1 years old than patients with normal BMI - who were 59.8±7.4 years old. Patients with hypertension, atrial fibrillation and obesity often had a persistent form of AF 71%. General assessment of the lipid profile indicated that only patients with obesity and hypothyroidism showed a significantly high level of triglycerides. (p<0.001). There was an increase in NT-proBNP (p=0.001) and galectin-3 (p=0.005). There was a consistent increase of the end-diastolic dimension of the left ventricle in the left atrium; thickening of the left ventricular posterior and the interventricular septum in compared groups proved equivocal, while the LVMMI (p<0.05) was significantly lower in patients with obesity than in the experimental group.Conclusion. The presence of obesity in patients with atrial fibrillation and arterial hypertension adversely affects certain biochemical and ultrasound parameters, however, many of the criteria characterizing cardiovascular risk and prognosis did not reveal significant differences, which requires further in-depth study of this problem and identification of a possible “obesity paradox” in the group of patients with atrial fibrillation, arterial hypertension and obesity.https://www.heartj.asia/jour/article/view/317progressingatrial fibrillationarterial hypertensionobesity
spellingShingle L. D. Khidirova
D. A. Yakhontov
T. S. Kuropiy
S. A. Zenin
ATRIAL FIBRILLATION COMBINED WITH ARTERIAL HYPERTENSION AND OBESITY PARADOX
Евразийский Кардиологический Журнал
progressing
atrial fibrillation
arterial hypertension
obesity
title ATRIAL FIBRILLATION COMBINED WITH ARTERIAL HYPERTENSION AND OBESITY PARADOX
title_full ATRIAL FIBRILLATION COMBINED WITH ARTERIAL HYPERTENSION AND OBESITY PARADOX
title_fullStr ATRIAL FIBRILLATION COMBINED WITH ARTERIAL HYPERTENSION AND OBESITY PARADOX
title_full_unstemmed ATRIAL FIBRILLATION COMBINED WITH ARTERIAL HYPERTENSION AND OBESITY PARADOX
title_short ATRIAL FIBRILLATION COMBINED WITH ARTERIAL HYPERTENSION AND OBESITY PARADOX
title_sort atrial fibrillation combined with arterial hypertension and obesity paradox
topic progressing
atrial fibrillation
arterial hypertension
obesity
url https://www.heartj.asia/jour/article/view/317
work_keys_str_mv AT ldkhidirova atrialfibrillationcombinedwitharterialhypertensionandobesityparadox
AT dayakhontov atrialfibrillationcombinedwitharterialhypertensionandobesityparadox
AT tskuropiy atrialfibrillationcombinedwitharterialhypertensionandobesityparadox
AT sazenin atrialfibrillationcombinedwitharterialhypertensionandobesityparadox